Filtricine

company

About

Filtricine provides new solution to cancer care via Targeted Nutrients Deprivation.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$5M
Industries
Biotechnology,Health Care,Life Science,Medical
Founded date
Sep 6, 2017
Number Of Employee
1 - 10
Operating Status
Active

Filtricine, Inc. is a venture-backed, clinical stage biotech company based in Santa Clara, CA. We are developing a nutrient modulation platform which can identify metabolic vulnerabilities in cancers and exploit those vulnerabilities without the use of drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5M
Filtricine has raised a total of $5M in funding over 2 rounds. Their latest funding was raised on Oct 29, 2018 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 29, 2018 Seed $5M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Filtricine is funded by 1 investors. Trancos Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Trancos Ventures Seed